<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Braz. J. Microbiol</journal-id><journal-id journal-id-type="publisher-id">bjm</journal-id><journal-title-group><journal-title>Brazilian Journal of Microbiology</journal-title></journal-title-group><issn pub-type="ppub">1517-8382</issn><issn pub-type="epub">1678-4405</issn><publisher><publisher-name>Sociedade Brasileira de Microbiologia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26273275</article-id><article-id pub-id-type="pmc">4507552</article-id><article-id pub-id-type="doi">10.1590/S1517-838246220140096</article-id><article-categories><subj-group subj-group-type="heading"><subject>Veterinary Microbiology</subject></subj-group></article-categories><title-group><article-title>Molecular characterization of Brazilian equid herpesvirus type 1
strains based on neuropathogenicity markers</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mori</surname><given-names>Enio</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="aff" rid="aff03">3</xref><xref rid="c01" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Lara</surname><given-names>Maria do Carmo C.S.H.</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Cunha</surname><given-names>Elenice M.S.</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Villalobos</surname><given-names>Eliana M.C.</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Mori</surname><given-names>Claudia M.C.</given-names></name><xref ref-type="aff" rid="aff03">3</xref></contrib><contrib contrib-type="author"><name><surname>Soares</surname><given-names>Rodrigo M.</given-names></name><xref ref-type="aff" rid="aff04">4</xref></contrib><contrib contrib-type="author"><name><surname>Brand&#x000e3;o</surname><given-names>Paulo E.</given-names></name><xref ref-type="aff" rid="aff04">4</xref></contrib><contrib contrib-type="author"><name><surname>Fernandes</surname><given-names>Wilson R.</given-names></name><xref ref-type="aff" rid="aff05">5</xref></contrib><contrib contrib-type="author"><name><surname>Richtzenhain</surname><given-names>Leonardo J.</given-names></name><xref ref-type="aff" rid="aff04">4</xref></contrib></contrib-group><aff id="aff01"><label>1</label>Instituto Pasteur, S&#x000e3;o Paulo, SP, Brasil, Instituto Pasteur, S&#x000e3;o Paulo, SP,
Brazil.</aff><aff id="aff02"><label>2</label>Instituto Biol&#x000f3;gico, Instituto Biol&#x000f3;gico, S&#x000e3;o Paulo, SP, Brasil, Instituto Biol&#x000f3;gico, S&#x000e3;o Paulo, SP,
Brazil.</aff><aff id="aff03"><label>3</label>Universidade de S&#x000e3;o Paulo, Departamento de Patologia, Faculdade de Medicina Veterin&#x000e1;ria e Ci&#x000ea;ncia
Animal, Universidade de S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP, Brasil, Departamento de Patologia, Faculdade de
Medicina Veterin&#x000e1;ria e Ci&#x000ea;ncia Animal, Universidade de S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP,
Brazil.</aff><aff id="aff04"><label>4</label>Universidade de S&#x000e3;o Paulo, Departamento de Medicina Veterin&#x000e1;ria Preventiva
e Sa&#x000fa;de Animal, Faculdade de Medicina Veterin&#x000e1;ria e
Zootecnia, Universidade de S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP, Brasil, Departamento de Medicina Veterin&#x000e1;ria Preventiva
e Sa&#x000fa;de Animal, Faculdade de Medicina Veterin&#x000e1;ria e Zootecnia, Universidade de
S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP, Brazil.</aff><aff id="aff05"><label>5</label>Universidade de S&#x000e3;o Paulo, Departamento de Cl&#x000ed;nica M&#x000e9;dica, Faculdade de Medicina Veterin&#x000e1;ria e Ci&#x000ea;ncia
Animal, Universidade de S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP, Brasil, Departamento de Cl&#x000ed;nica M&#x000e9;dica, Faculdade de
Medicina Veterin&#x000e1;ria e Ci&#x000ea;ncia Animal, Universidade de S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP,
Brazil.</aff><author-notes><corresp id="c01">Send correspondence to E. Mori. Instituto Pasteur, Alameda Santos
416, 01418-000 S&#x000e3;o Paulo, SP, Brazil. E-mail:
<email>eniomori@gmail.com</email>.</corresp><fn id="fn01" fn-type="other"><p>Associate Editor: Jo&#x000e3;o Pessoa Ara&#x000fa;jo Junior</p></fn></author-notes><pub-date pub-type="epub"><day>01</day><month>6</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2015</year></pub-date><volume>46</volume><issue>2</issue><fpage>565</fpage><lpage>570</lpage><history><date date-type="received"><day>01</day><month>2</month><year>2014</year></date><date date-type="accepted"><day>30</day><month>10</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015, Sociedade Brasileira de
Microbiologia</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>All the content of the journal, except where otherwise noted, is
licensed under a Creative Commons License CC BY-NC.</license-p></license></permissions><abstract><p>Partial nucleotide sequences of <italic>ORF72</italic> (glycoprotein D,
<italic>gD</italic>), <italic>ORF64</italic> (infected cell protein 4, ICP4)
and <italic>ORF30</italic> (DNA polymerase) genes were compared with
corresponding sequences of EHV-1 reference strains to characterize the molecular
variability of Brazilian strains. Virus isolation assays were applied to 74
samples including visceral tissue, total blood, cerebrospinal fluid (CSF) and
nasal swabs of specimens from a total of 64 animals. Only one CSF sample
(Iso07/05 strain) was positive by virus isolation in cell culture. EHV-1
Iso07/05 neurologic strain and two abortion visceral tissues samples (Iso11/06
and Iso33/06) were PCR-positive for ORF33 (glycoprotein B, <italic>gB</italic>)
gene of EHV-1. A sequence analysis of the ORF72, <italic>ORF64</italic> and
<italic>ORF30</italic> genes from three EHV-1 archival strains (A3/97,
A4/72, A9/92) and three clinical samples (Iso07/05, Iso11/06 and Iso33/06)
suggested that among Brazilian EHV-1 strains, the amplified region of the
<italic>gD</italic> gene sequence is highly conserved. Additionally, the
analysis of <italic>ICP4</italic> gene showed high nucleotide and amino acid
identities when compared with genotype P strains, suggesting that the EHV-1
Brazilian strains belonged to the same group. All the EHV-1 Brazilian strains
were classified as non-neuropathogenic variants (N752) based on the
<italic>ORF30</italic> analysis. These findings indicate a high conservation
of the gD-, <italic>ICP4</italic>- and <italic>ORF30</italic>-encoding
sequences. Different pathotypes of the EHV-1 strain might share identical genes
with no specific markers, and tissue tropism is not completely dependent on the
<italic>gD</italic> envelope, immediate-early <italic>ICP4</italic> and DNA
polymerase proteins.</p></abstract><kwd-group><kwd>equid herpesvirus type 1</kwd><kwd>equid Brazilian herpesvirus</kwd><kwd><italic>ICP4</italic> gene (<italic>ORF64</italic>)</kwd><kwd>glycoprotein D gene (<italic>ORF72</italic>)</kwd><kwd>DNA polymerase gene (<italic>ORF30</italic>)</kwd></kwd-group><counts><fig-count count="1"/><table-count count="2"/><equation-count count="0"/><ref-count count="24"/><page-count count="6"/></counts></article-meta></front><body><p>Equid herpesvirus 1 (EHV-1) is the major cause of different clinical syndromes in horses,
such as respiratory disease, abortion, neonatal deaths, and neurological disorders. It
has been recognized as a cause of substantial financial losses to the horse industry
throughout the world (<xref rid="B01" ref-type="bibr">Allen and Bryans, 1986</xref>;
<xref rid="B09" ref-type="bibr">Gryspeerdt <italic>et al.</italic>,
2010</xref>).</p><p>Until recently, EHV-1 disease outbreaks usually manifested as abortions in late
gestation; however, the frequency and severity of EHV-1 neurological diseases throughout
North America and Europe have increased in recent years, and EHV-1 is now considered a
potentially emerging disease of the horse by the US Department of Agriculture (<xref rid="B22" ref-type="bibr">Vandekerckhove <italic>et al.</italic>, 2010</xref>).
Research studies have been performed suggesting that a molecular variation in the EHV-1
genome is playing a role in these changes in the disease behavior, which could indicate
evolution of the viral agent (<xref rid="B19" ref-type="bibr">Pagamjav <italic>et
al.</italic>, 2005</xref>; <xref rid="B18" ref-type="bibr">Nugent <italic>et
al.</italic>, 2006</xref>). In Brazil, the first isolation of EHV-1 was recorded
in 1966 from an equine-aborted fetus (<xref rid="B17" ref-type="bibr">Nilsson and
Correa, 1966</xref>). After that, several isolates have been recovered, mainly from
aborted fetuses; however, only recently a case report of EHV-1-related neurological
signs in an adult mare was described (<xref rid="B12" ref-type="bibr">Lara <italic>et
al.</italic>, 2008</xref>).</p><p>Restriction fragment length polymorphism (RFLP) analysis of whole DNA viral has been used
to detect molecular variation among EHV-1 isolates. There are at least two
electropherotype patterns of EHV-1 detected by restriction enzyme digestion designated
EHV-1 P and EHV-1 B (<xref rid="B02" ref-type="bibr">Allen <italic>et al.</italic>,
1983</xref>). Based on previous studies, in the 3&#x02032;-end and downstream of the open
reading frame (ORF) 64 gene (infected cell protein 4 - <italic>ICP4</italic> gene),
natural recombination between EHV-1 and EHV-4 by the exchange of homologous fragments
could be associated with the major molecular differences between isolates EHV-1 P and
EHV-1 B (<xref rid="B19" ref-type="bibr">Pagamjav <italic>et al.</italic>, 2005</xref>).
The EHV-1 B genotype should be a result of this recombination between the progenitors of
the EHV-1 P genotype and EHV-4. The <italic>ICP4</italic> is an important
transcriptional activator, essential for progression beyond the immediate-early phase of
infection, associated with lytic infection in HSV-1 (<xref rid="B20" ref-type="bibr">Pinnoji <italic>et al.</italic>, 2007</xref>). The <italic>ICP4</italic> product is
involved in the regulation of gene expression and interaction with host factors, and
this intertypic recombination could cause some alteration of EHV-1 virulence and
neuropathogenicity in hamsters. The abortigenic genotype (EHV-1 B) may have originated
from the neuropathogenic (EHV-1 P) after exchange of a fragment in the
<italic>ICP4</italic> gene between EHV-1 and EHV-4 (<xref rid="B19" ref-type="bibr">Pagamjav <italic>et al.</italic>, 2005</xref>).</p><p>Glycoprotein D (<italic>gD</italic>) is responsible for virus entry and spread into a
host cell, being major determinant of host cell tropism and may also be a factor
involved in the neuropathogenicity of EHV-1 by modulating neurovirulence and
neuroinvasion (<xref rid="B13" ref-type="bibr">Mettenleiter, 2003</xref>; <xref rid="B24" ref-type="bibr">Whalley <italic>et al.</italic>, 2007</xref>; <xref rid="B03" ref-type="bibr">Azab and Osterrieder, 2012</xref>).</p><p>EHV-1 molecular epidemiology research has identified a single nucleotide polymorphism
(SNP) in the catalytic subunit (Pol) of the viral DNA polymerase
(<italic>ORF30</italic>) gene, causing a substitution of asparagine (N) by aspartic acid
(D) at amino acid position 752. This substitution showed a highly statistically
significant (p &#x0003c; 0.0001) correlation with paralytic compared with non-paralytic
disease outbreaks (<xref rid="B18" ref-type="bibr">Nugent <italic>et al.</italic>,
2006</xref>).</p><p>To the authors' knowledge, there have been few published articles on molecular
variability of the EHV-1 Brazilian isolates. Despite the fact that ORF37 (similar to
HSV-1 UL24) is considered a neuropathogenicity determinant of EHV-1 in the mouse
encephalitis model (<xref rid="B11" ref-type="bibr">Kasem <italic>et al.</italic>,
2010</xref>), <xref rid="B05" ref-type="bibr">Carvalho <italic>et al.</italic>
(2012)</xref> showed no molecular divergences on the partial sequencing of this
region derived from two Brazilian EHV-1 isolates (A4/72 and A3/97) with high and low
virulence in the mice model, respectively (<xref rid="B16" ref-type="bibr">Mori
<italic>et al.</italic>, 2012</xref>).</p><p>The purpose of this study was to investigate some putative pathogenicity markers
(<italic>ICP4</italic>, <italic>gD</italic> and viral DNA polymerase genes) in EHV-1
Brazilian strains to form a basis for comparison of partial nucleotide sequences with
corresponding sequences of EHV-1 reference strains from DNA databases deposited in the
GenBank (NCBI) to gather insights into the validity of such markers.</p><p>Three abortogenic (A4/72, A9/92 and A3/97) EHV-1 Brazilian archival strains, provided by
the Biological Institute (Department of Agriculture, Sao Paulo State, Brazil), were
recovered originally from organs (lungs, spleen and liver) of aborted fetuses. Viruses
were propagated in Vero (CRL-1587, ATCC) and E-Derm (CCL-57, ATCC) cell lines and
maintained in Eagle's minimal essential medium (EMEM) supplemented with 5% fetal bovine
serum (FBS) at 37 &#x000b0;C in a humidified atmosphere of 5% CO<sub>2</sub>.</p><p>Seventy-four clinical specimens from horses (fragments of visceral tissues, total blood,
CSF and nasal swab) were submitted for routine diagnostic tests to the Rabies and Viral
Encephalitis subdivision of the Biological Institute (Department of Agriculture, Sao
Paulo, Brazil) between 2005 and 2007 (<xref rid="t01" ref-type="table">Table 1</xref>).
Sixty-four horses with an unknown vaccination history, and suggestive findings of EHV-1
infection [abortion (n = 25), neurological disease (n = 29), respiratory disease (n = 9)
and perinatal disease (n = 1)] were sampled by private veterinarians from eight
different Brazilian states: the Southeastern region [Sao Paulo state (n = 45), Minas
Gerais state (n = 13), and Rio de Janeiro state (n = 1)]; the Midwestern region [Goias
state (n = 1)]; South region [Parana state (n = 1), and Rio Grande do Sul (n = 1)]; and
the Northeastern region [Rio Grande do Norte (n = 1), and Ceara (n = 1)].</p><table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><title>Animal groups (n = 64) and samples (n = 74) that were examined for the
presence of EHV-1 by virus isolation and PCR during 2005 to 2007.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Group</th><th valign="top" align="center" rowspan="1" colspan="1">Number of animals</th><th colspan="6" valign="top" align="center" rowspan="1">Specimens</th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"/><th colspan="6" valign="top" align="left" rowspan="1">
<hr/>
</th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">VT</th><th valign="top" align="center" rowspan="1" colspan="1">BL</th><th valign="top" align="center" rowspan="1" colspan="1">NT</th><th valign="top" align="center" rowspan="1" colspan="1">CSF</th><th valign="top" align="center" rowspan="1" colspan="1">NS</th><th valign="top" align="center" rowspan="1" colspan="1">Pl</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Abortion</td><td valign="top" align="center" rowspan="1" colspan="1">25</td><td valign="top" align="center" rowspan="1" colspan="1">24 (fetus)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">1 (fetus)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Neurological disease</td><td valign="top" align="center" rowspan="1" colspan="1">29</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="center" rowspan="1" colspan="1">14</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Respiratory disease</td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Perinatal disease</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">1 (foal)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total</td><td valign="top" align="center" rowspan="1" colspan="1">64</td><td valign="top" align="center" rowspan="1" colspan="1">25</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">14</td><td valign="top" align="center" rowspan="1" colspan="1">19</td><td valign="top" align="center" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><fn id="TFN01"><p>(-): Not collected; VT: visceral tissues (lung, liver and spleen); BL: total
blood; NT: neuronal tissues; CSF: cerebrospinal fluid; NS: nasal swab; Pl:
placenta.</p></fn></table-wrap-foot></table-wrap><p>Virus isolation (VI) was attempted with clinical samples (20% w/v brain or CSF) collected
at necropsy and inoculated onto a monolayer of Vero (CRL-1587, ATCC) and E-derm (CCL-57,
ATCC) cells. When these cells exhibited a cytopathic effect (CPE), the identification of
isolates was performed according to previously published methods (<xref rid="B16" ref-type="bibr">Mori <italic>et al.</italic>, 2012</xref>).</p><p>DNA extraction of the EHV-1 Brazilian strains and specimens were conducted following a
previously described method (<xref rid="B06" ref-type="bibr">Chomczynski, 1993</xref>).
PCR screening tests (hemi-nested) were performed using primers that hybridize to highly
conserved <italic>gB</italic> gene regions that differentiate between EHV-1 [P1 forward
5&#x02032;-CTTGTGAGATCTAACC GCAC-3&#x02032;/P2 outer reverse 5&#x02032;-GGGTATAGAGCTTTC ATGGG-3&#x02032; and P1/P3 inner
reverse 5&#x02032;-GCGTTATAGC TATCACGTCC-3&#x02032;] (<xref rid="B15" ref-type="bibr">Mori <italic>et
al.</italic>, 2009</xref>) and EHV-4 [P4 forward 5&#x02032;-CTGCTGTCATTATGCAGGGA-3&#x02032;/P5
outer reverse 5&#x02032;-CGTCTTCTCGAAGACGGGTA-3&#x02032; and P4/P6 inner reverse
5&#x02032;-CGCTAGTGTCATCATCGTCG-3&#x02032;] (<xref rid="B23" ref-type="bibr">Varrasso <italic>et
al.</italic>, 2001</xref>). Next, three different sets of primers representing
different regions of EHV-1 were used in positive amplification samples:
<italic>ICP4</italic> gene [P7 forward 5&#x02032;-ACGCCCCCTTCGTTCCTC-3&#x02032;/P8 reverse
5&#x02032;-CGCTCCACCTCGGTCCTG-3&#x02032;] (<xref rid="B04" ref-type="bibr">Borchers <italic>et
al.</italic>, 1998</xref>), <italic>gD</italic> gene [P9 forward
5&#x02032;-ATGTCTACCTTCAAGCTT-3&#x02032;/P10 reverse 5&#x02032;-TTACGGAAGCTGGGTATA-3&#x02032;] (<xref rid="B07" ref-type="bibr">Galosi <italic>et al.</italic>, 2001</xref>) and the DNA polymerase
enzyme gene (<italic>ORF30</italic>) [P11 forward 5&#x02032;-CCACAAACTTGATAAAC ACG-3&#x02032;/P12
reverse 5&#x02032;-GCGCTACTTCTGAAAACG-3&#x02032;] (<xref rid="B18" ref-type="bibr">Nugent <italic>et
al.</italic>, 2006</xref>). Amplification was performed in a reaction mixture of
total volume 50 mL containing 0.5 mg of DNA sample, 0.5 mM of each primer, 0.2 mM of
each dNTP mixture, 2.5 units of Platinum Taq DNA polymerase (Invitrogen Brasil Ltda, Sao
Paulo, Brazil), 1 X PCR buffer (20 mM of Tris-HCl pH 8.4, 50 mM of KCl), 1.5 mM of MgCl
and ultra-pure water QS. Amplification was carried out in a thermal cycler (Eppendorf
Mastercycler Gradient PTC-200, Eppendorf AG, Hamburg, Germany) under the conditions
reported in <xref rid="t02" ref-type="table">Table 2</xref>.</p><table-wrap id="t02" orientation="portrait" position="float"><label>Table 2</label><caption><title>Thermal cycling programs for PCR of EHV-4 gB primers and EHV-1 gB, gD, ICP4
and ORF30 primers.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Step</th><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1">EHV-4</th><th colspan="4" valign="bottom" align="center" rowspan="1">EHV-1</th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="left" rowspan="1" colspan="1">
<hr/>
</th><th colspan="4" valign="bottom" align="left" rowspan="1">
<hr/>
</th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1">gB</th><th valign="bottom" align="center" rowspan="1" colspan="1">gB</th><th valign="bottom" align="center" rowspan="1" colspan="1">gD</th><th valign="bottom" align="center" rowspan="1" colspan="1">ICP4</th><th valign="bottom" align="center" rowspan="1" colspan="1">ORF30</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">Initial denaturation</td><td valign="top" align="center" rowspan="1" colspan="1">95 &#x000b0;C (5-min)</td><td valign="top" align="center" rowspan="1" colspan="1">94 &#x000b0;C (5-min)</td><td valign="top" align="center" rowspan="1" colspan="1">94 &#x000b0;C (5-min)</td><td valign="top" align="center" rowspan="1" colspan="1">96 &#x000b0;C (3-min)</td><td valign="top" align="center" rowspan="1" colspan="1">94 &#x000b0;C (4-min)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">Denaturation</td><td valign="top" align="center" rowspan="1" colspan="1">95 &#x000b0;C (30-s)</td><td valign="top" align="center" rowspan="1" colspan="1">94 &#x000b0;C (1-min)</td><td valign="top" align="center" rowspan="1" colspan="1">94 &#x000b0;C (1-min)</td><td valign="top" align="center" rowspan="1" colspan="1">94 &#x000b0;C (30-s)</td><td valign="top" align="center" rowspan="1" colspan="1">94 &#x000b0;C (30-s)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">Annealing</td><td valign="top" align="center" rowspan="1" colspan="1">60 &#x000b0;C (30-s)</td><td valign="top" align="center" rowspan="1" colspan="1">60 &#x000b0;C (1-min)</td><td valign="top" align="center" rowspan="1" colspan="1">50 &#x000b0;C (1-min)</td><td valign="top" align="center" rowspan="1" colspan="1">64 &#x000b0;C (30-s)</td><td valign="top" align="center" rowspan="1" colspan="1">56 &#x000b0;C (1-min)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">Extension</td><td valign="top" align="center" rowspan="1" colspan="1">72 &#x000b0;C (1-min)</td><td valign="top" align="center" rowspan="1" colspan="1">72 &#x000b0;C (1-min)</td><td valign="top" align="center" rowspan="1" colspan="1">72 &#x000b0;C (90-s)</td><td valign="top" align="center" rowspan="1" colspan="1">72 &#x000b0;C (1-min)</td><td valign="top" align="center" rowspan="1" colspan="1">72 &#x000b0;C (2-min)</td></tr><tr><td colspan="2" valign="top" align="left" rowspan="1">Number of cycles (step 2 to
4)</td><td valign="top" align="center" rowspan="1" colspan="1">35</td><td valign="top" align="center" rowspan="1" colspan="1">35</td><td valign="top" align="center" rowspan="1" colspan="1">25</td><td valign="top" align="center" rowspan="1" colspan="1">35</td><td valign="top" align="center" rowspan="1" colspan="1">35</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">Final extension</td><td valign="top" align="center" rowspan="1" colspan="1">72 &#x000b0;C (5-min)</td><td valign="top" align="center" rowspan="1" colspan="1">72 &#x000b0;C (7-min)</td><td valign="top" align="center" rowspan="1" colspan="1">72 &#x000b0;C (6-min)</td><td valign="top" align="center" rowspan="1" colspan="1">72 &#x000b0;C (6-min)</td><td valign="top" align="center" rowspan="1" colspan="1">72 &#x000b0;C (10-min)</td></tr></tbody></table></table-wrap><p>A commercial kit (GFX PCR DNA and Gel Band Purification Kit, GE Healthcare, Uppsala,
Sweden) was used for the purification of amplified DNA fragments. Then, bidirectional
cycle sequencing was performed using the dideoxynucleotide chain-termination method (Big
Dye Terminator v.3.1 Cycle Sequencing Kit, Applied Biosystems, Foster City, California,
USA) according to the manufacturer's instructions. Sequence reaction products were
analyzed on an automatic DNA sequencer (ABI Prism 377 Genetic Analyzer, Applied
Biosystems Foster City, California, USA). The sequence quality analysis was examined by
the <italic>Phred</italic> program (<ext-link ext-link-type="uri" xlink:href="http://asparagin.cenargen.embrapa.br/phph/">http://asparagin.cenargen.embrapa.br/phph/</ext-link>). The lower threshold of
acceptability for the generation of consensus sequences was set at a
<italic>Phred</italic> score of 20 for each base. Next, the final sequences were
assembled using the contig assembly program (CAP) of the software BioEdit v.7.0.9.0
(<xref rid="B10" ref-type="bibr">Hall, 1999</xref>). Sequences of each EHV-1 strain
and homologous sequences retrieved from GenBank were aligned by the ClustalW method
using Bioedit v.7.0.9.0 (<xref rid="B10" ref-type="bibr">Hall, 1999</xref>). Nucleotide
and amino acid identities of the translated sequences were calculated using Bioedit
v.7.0.9.0 (<xref rid="B10" ref-type="bibr">Hall, 1999</xref>).</p><p>Phylogenetic tree using the sequences from the <italic>ORF64</italic> gene region were
carried out using the neighbor-joining (NJ) algorithm and the maximum composite
likelihood (MCL) evolutionary model with software Mega version 6.0.6 (<xref rid="B21" ref-type="bibr">Tamura <italic>et al.</italic>, 2013</xref>). The reliability of the
NJ phylogenetic trees was evaluated by analyzing 1,000 bootstrap repetitions, and the
virus HHV-3 strain Dumas (accession number NC001348) was used as an outgroup. The
genomic partial sequences of the EHV-1 strains [Ab4p (accession number AY665713), KyD
(accession number AB279610), V592 (accession number AY464052), RacL11 (accession number
AB279607), KyA (accession number M629230), Ab1 (accession number M60946), HVS25A
(accession number M59773), 98c12 (accession number AB183143), 97c5 (accession number
AB183141), 97c7 (accession number AB182650) and 97c9 (accession number AB183142)], the
EHV-9 strain P19 (accession number NC011644) and the EHV-4 strain NS80567 (accession
number AF030027) were obtained from DNA databases that had been deposited in the GenBank
(NCBI) and used for comparison purposes.</p><p>Virus isolation assays were applied to 74 samples including visceral tissue, total blood,
cerebrospinal fluid (CSF) and nasal swabs of farms specimens from a total of 64 animals
(<xref rid="t01" ref-type="table">Table 1</xref>). Only one cerebrospinal fluid
(CSF) sample (namely strain Iso07/05) of a mare with a neurological disorder from a
riding school in Ribeirao Pires County (Sao Paulo State, Southeastern Brazil) caused
herpesvirus CPE after the first passage in ED cells (<xref rid="B12" ref-type="bibr">Lara <italic>et al.</italic>, 2008</xref>). EHV-1 Iso07/05 neurologic strain and
two abortion visceral tissue (VT) samples (Iso11/06 and Iso33/06) were positive for
EHV-1 PCR with <italic>gB</italic> primers. Iso11/06 and Iso33/06 samples were
originated from Belo Horizonte County (Minas Gerais State, Southeastern Brazil) and
Pirassununga County (Sao Paulo State, Southeastern Brazil), respectively.</p><p>The use of <italic>gD</italic>, <italic>ICP4</italic> and <italic>ORF30</italic> as
primers showed that the Brazilian archival EHV-1 strains (A4/72 and A3/97) were positive
by PCR, whereas A9/92 strain was positive only for <italic>ICP4</italic> primers.
<italic>ICP4</italic>, <italic>gD</italic> and <italic>ORF30</italic> regions of the
EHV-1 Brazilian sequences were deposited in GenBank (accession numbers EU094656,
EU094657, EU088186, EU088187, EU410444, EU410445 and EU094655). EHV-1 strains (Iso07/05,
Iso11/06 and Iso33/06) were PCR-positive using <italic>gD</italic>,
<italic>ICP4</italic> and <italic>ORF30</italic> gene primers. The positive PCR
amplicons <italic>gD</italic>, <italic>ICP4</italic> and <italic>ORF30</italic> genes
were partially sequenced (GenBank accession numbers EU052212, EU169121, EU410443,
JN390439, EU825794, EU857541, JN390440, EU825795, and FJ755482). The <italic>gD</italic>
gene amplicon lengths were 935 nt and encoded 310 amino acids. At the nucleotide level
of the <italic>gD</italic> gene, the Brazilian EHV-1 isolates and clinical samples
showed 100% identity among them. Comparing Brazilian EHV-1 isolates and clinical
specimens with those deposited in GenBank, it was observed that nucleotide and predicted
amino acid sequences of the <italic>gD</italic> exhibited high identities (99.6&#x02013;100% and
99&#x02013;100%, respectively), differing in few nucleotides and resulting in low rates of amino
acid change (<inline-supplementary-material xlink:href="1517-8382-bjm-46-2-565-suppl01.pdf" mimetype="application" mime-subtype="pdf" id="d35e814" content-type="local-data">Supplementary Figure S3</inline-supplementary-material>). The
results suggested that among Brazilian EHV-1 strains, the <italic>gD</italic> gene is
highly conserved, thus supporting the use of vaccines that contain DNA or subunits
related to this region.</p><p>Although there are dramatic differences in the virulence and tissue tropism between A4/72
and A3/97 after intranasal inoculation with the same viruses (<xref rid="B16" ref-type="bibr">Mori <italic>et al.</italic>, 2012</xref>), the highly conserved
region of <italic>gD</italic> do not explain the pathogenetic differences of the EHV-1
Brazilian isolates. However, a strain with different pathogenicity in mice might have
identical <italic>gD</italic>s, a fact not reported previously.</p><p>In contrast to the attenuated EHV-1 strains (KyA, KyD and RacL11) used as vaccine,
drastic mutations in <italic>gD</italic> sequence, such as deletion, inversion, and
insertion, were not found in the strains here analyzed (<inline-supplementary-material xlink:href="1517-8382-bjm-46-2-565-suppl01.pdf" mimetype="application" mime-subtype="pdf" id="d35e840" content-type="local-data">Supplementary Figure S1</inline-supplementary-material>). A
possible explanation for DNA mutations in KyA, KyD and RacL11 strains may be due to
serial passage in hamsters and culture cells (<xref rid="B14" ref-type="bibr">Molinkova
<italic>et al.</italic>, 2004</xref>; <xref rid="B08" ref-type="bibr">Ghanem
<italic>et al.</italic>, 2007</xref>).</p><p>The nucleotide sequence of the <italic>ICP4</italic> region was 309nt long and encoded
102 amino acids. At both the nucleotide and the amino acid levels of the
<italic>ICP4</italic>, the Brazilian EHV-1 isolates and clinical samples showed 100%
identity among them. Comparison of the <italic>ICP4</italic> nucleotide and amino acid
sequences obtained from Brazilian EHV-1 isolates and clinical specimens with those from
the EHV-1 genotype P strains (Ab4p and V592) exhibited 100% identity, suggesting that
these viruses belonged to the same group (<xref rid="B19" ref-type="bibr">Pagamjav
<italic>et al.</italic>, 2005</xref>). The genealogic tree for the
<italic>ORF64</italic> gene constructed with the sequences analyzed in this study
clustered in only one group named genotype P (<xref rid="f01" ref-type="fig">Figure
1</xref>).</p><fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Neighbor-joining genealogic tree using partial <italic>ORF64</italic>
nucleotide sequence (nt) from EHV-1 Brazilian strains (A4/72, A9/92, A3/97,
Iso11/06, Iso07/05 and Iso33/06), GenBank reference EHV-1 strains (Ab4, V592,
98c12, 97c5, 97c7 and 97c9) and GenBank reference alphaherpesviruses strains
(EHV-9 strain P19, EHV-4 strain NS80567 and HHV-3 strain Dumas). The numbers at
each node are bootstrap values. EHV-1 genotype P strains [A4/72 (accession
number EU094657), A9/92 (accession number EU094655), A3/97 (accession number
EU094656), Iso11/06 (accession number EU825794), Iso07/05 (accession number
EU169121), Iso33/06 (accession number EU825795), Ab4p (accession number
AY665713) and V592 (accession number AY464052)], EHV-1 genotype B strains [98c12
(accession number AB183143), 97c5 (accession number AB183141), 97c7 (accession
number AB182650) and 97c9 (accession number AB183142)], EHV-9 strain P19
(accession number NC011644), EHV-4 strain NS80567 (accession number AF030027)
and HHV-3 strain Dumas (accession number NC001348).</title></caption><graphic xlink:href="1517-8382-bjm-46-2-565-gf01"/></fig><p>On the other hand, the nucleotide sequences of the <italic>ICP4</italic> in Brazilian
EHV-1 strains exhibited 69.6% nucleotide identity with EHV-1 genotype B strains (97c5,
97c7, 97c9 and 98c12) and EHV-4 (strain NS80567). In addition, the Brazilian strains
exhibited 49% amino acid identity with EHV-1 genotype B strains and EHV-4.</p><p>
<xref rid="B19" ref-type="bibr">Pagamjav <italic>et al.</italic> (2005)</xref> suggested
that the intertypic recombination in the <italic>ICP4</italic> gene could cause an
alteration in EHV-1 virulence and neuropathogenicity in the hamster model. The EHV-1 P
strains were correlated with neuropathogenic behavior in hamster model. However, as
occurred with the <italic>gD</italic> gene region, the involvement of this gene in
neuropathogenicity in mice could not be confirmed based on the results of the
<italic>ICP4</italic> nucleotide sequencing from the EHV-1 Brazilian isolates (<xref rid="B16" ref-type="bibr">Mori <italic>et al.</italic>, 2012</xref>).</p><p>The <italic>ORF30</italic> nucleotide sequences were 426nt long and encoded 141 amino
acids. The DNA polymerase gene region of the EHV-1 Brazilian isolates and clinical
specimens showed 100% nucleotide identity with the non-neuropathogenic variant (N752)
EHV-1 strain V592. Nucleotide and amino acid identity among the Brazilian strains and
the neuropathogenic variant (D752) was 99.7% and 99.2%, respectively.</p><p>Although strain Iso07/05 was recovered from CSF and classified as a neurotropic isolate,
all the EHV-1 Brazilian strains were classified as non-neuropathogenic (N752) in the
catalytic subunit (Pol) of the viral DNA polymerase gene (<xref rid="B18" ref-type="bibr">Nugent <italic>et al.</italic>, 2006</xref>). <xref rid="B18" ref-type="bibr">Nugent <italic>et al.</italic> (2006)</xref> found that
approximately 15% of isolates from cases of EHV-1 neurological disease did not contain
the mutation in this gene.</p><p>The A9/92 strain could have differences in its DNA composition in comparison with other
EHV-1 strains, which could explain the different ways of spreading and the neurological
signs A9/92 strain causes in mice model (<xref rid="B16" ref-type="bibr">Mori <italic>et
al.</italic>, 2012</xref>).</p><p>This is one of the first molecular epidemiological investigations into EHV-1 Brazilian
isolates, and it does not reveal any molecular variation in the <italic>ICP4</italic>,
<italic>gD</italic> and viral DNA polymerase gene regions among these strains. These
results suggest that other factors, such as immune response, could be involved in the
neuropathogenicity of EHV-1 in the mouse models (<xref rid="B16" ref-type="bibr">Mori
<italic>et al.</italic>, 2012</xref>). In conclusion, different pathotypes of
EHV-1 might share identical genes with no specific markers, and tissue tropism is not
completely dependent on the <italic>gD</italic> envelope, immediate-early
<italic>ICP4</italic> and DNA polymerase proteins. Further studies of other
potential neurovirulence markers are required to clarify the relationship between
molecular variation and enhanced virulence in the mouse model, which may help elucidate
the neuropathogenicity of particular strains of EHV-1.</p></body><back><ack><title>Acknowledgments</title><p>This work was supported by the S&#x000e3;o Paulo Research Foundation (FAPESP), grant numbers
2007/58861-0 and 2005/56819-1, and the National Council for Scientific and
Technological Development (CNPq), grant number 473735/2008-3.</p></ack><ref-list><title>References</title><ref id="B01"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>G</given-names></name><name><surname>Bryans</surname><given-names>J</given-names></name></person-group><year>1986</year><article-title>Molecular epizootiology, pathogenesis, and prophylaxis of equine
herpesvirus-1 infections</article-title><source>Prog Vet Microbiol Immunol</source><volume>2</volume><fpage>78</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">2856183</pub-id></element-citation></ref><ref id="B02"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>GP</given-names></name><name><surname>Yeargan</surname><given-names>MR</given-names></name><name><surname>Turtinen</surname><given-names>LW</given-names></name><etal/></person-group><year>1983</year><article-title>Molecular epizootiologic studies of equine herpesvirus-1
infections by restriction endonuclease fingerprinting of viral
DNA</article-title><source>Am J Vet Res</source><volume>44</volume><fpage>263</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">6299145</pub-id></element-citation></ref><ref id="B03"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azab</surname><given-names>W</given-names></name><name><surname>Osterrieder</surname><given-names>N</given-names></name></person-group><year>2012</year><article-title>Glycoproteins D of equine herpesvirus type 1 (EHV-1) and EHV-4
determine cellular tropism independently of integrins</article-title><source>J Virol</source><volume>86</volume><fpage>2031</fpage><lpage>2044</lpage><pub-id pub-id-type="pmid">22171258</pub-id></element-citation></ref><ref id="B04"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Borchers</surname><given-names>K</given-names></name><name><surname>Wolfinger</surname><given-names>U</given-names></name><name><surname>Schellenbach</surname><given-names>A</given-names></name><etal/></person-group><year>1998</year><source>Equine herpesvirus type 1 and trigeminal ganglia of naturally infected
horses: detection of DNA and latency associated transcripts</source><person-group person-group-type="editor"><name><surname>Wernery</surname><given-names>U</given-names></name><name><surname>Wade</surname><given-names>J</given-names></name><name><surname>Mumford</surname><given-names>J</given-names></name><etal/></person-group><conf-name>Proceedings of the Eighth International Conference on Equine
Infectious Diseases</conf-name><publisher-name>R &#x00026;W Publications</publisher-name><publisher-loc>Dubai</publisher-loc><fpage>147</fpage><lpage>152</lpage></element-citation></ref><ref id="B05"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>RF</given-names></name><name><surname>Spilki</surname><given-names>FR</given-names></name><name><surname>Cunha</surname><given-names>EM</given-names></name><etal/></person-group><year>2012</year><article-title>Molecular data of UL24 homolog gene (ORF37) from Brazilian
isolates of equine herpesvirus type 1</article-title><source>Res Vet Sci</source><volume>93</volume><fpage>494</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">21684566</pub-id></element-citation></ref><ref id="B06"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chomczynski</surname><given-names>P</given-names></name></person-group><year>1993</year><article-title>A reagent for the single-step simultaneous isolation of RNA, DNA
and proteins from cell and tissue samples</article-title><source>Biotechniques</source><volume>15</volume><fpage>532</fpage><lpage>534</lpage><fpage>536</fpage><lpage>537</lpage><pub-id pub-id-type="pmid">7692896</pub-id></element-citation></ref><ref id="B07"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galosi</surname><given-names>CM</given-names></name><name><surname>Roza</surname><given-names>MVV</given-names></name><name><surname>Oliva</surname><given-names>GA</given-names></name><etal/></person-group><year>2001</year><article-title>A polymerase chain reaction for detection of equine herpesvirus-1
in routine diagnostic submissions of tissues from aborted
foetuses</article-title><source>J Vet Med B</source><volume>48</volume><fpage>341</fpage><lpage>346</lpage></element-citation></ref><ref id="B08"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghanem</surname><given-names>Y</given-names></name><name><surname>Ibrahim</surname><given-names>El-S</given-names></name><name><surname>Yamada</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>Molecular characterization of the equine herpesvirus 1 strains
RacL11 and Kentucky D</article-title><source>J Vet Med Sci</source><volume>69</volume><fpage>573</fpage><lpage>576</lpage><pub-id pub-id-type="pmid">17551238</pub-id></element-citation></ref><ref id="B09"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gryspeerdt</surname><given-names>AC</given-names></name><name><surname>Vandekerckhove</surname><given-names>AP</given-names></name><name><surname>Garr&#x000e9;</surname><given-names>B</given-names></name><etal/></person-group><year>2010</year><article-title>Differences in replication kinetics and cell tropism between
neurovirulent and non-neurovirulent EHV1 strains during the acute phase of
infection in horses</article-title><source>Vet Microbiol</source><volume>142</volume><fpage>242</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">19926232</pub-id></element-citation></ref><ref id="B10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>T</given-names></name></person-group><year>1999</year><article-title>BioEdit: a user-friendly biological sequence alignment editor and
analysis program for Windows 95/98/NT</article-title><source>Nucleic Acids Symp Ser</source><volume>41</volume><fpage>95</fpage><lpage>98</lpage></element-citation></ref><ref id="B11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasem</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>MH</given-names></name><name><surname>Yamada</surname><given-names>S</given-names></name><etal/></person-group><year>2010</year><article-title>The ORF37 (UL24) is a neuropathogenicity determinant of equine
herpesvirus 1 (EHV-1) in the mouse encephalitis model</article-title><source>Virology</source><volume>400</volume><fpage>259</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">20199788</pub-id></element-citation></ref><ref id="B12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lara</surname><given-names>MCCSH</given-names></name><name><surname>Cunha</surname><given-names>EMS</given-names></name><name><surname>Villalobos</surname><given-names>EMC</given-names></name><etal/></person-group><year>2008</year><article-title>First isolation of equine herpesvirus type 1 from a horse with
neurological disease in Brazil</article-title><source>Arq Inst Biol</source><volume>75</volume><fpage>221</fpage><lpage>224</lpage></element-citation></ref><ref id="B13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mettenleiter</surname><given-names>TC</given-names></name></person-group><year>2003</year><article-title>Pathogenesis of neurotropic herpesviruses: role of viral
glycoproteins inneuroinvasion and transneuronal spread</article-title><source>Virus Res</source><volume>92</volume><fpage>197</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">12686430</pub-id></element-citation></ref><ref id="B14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molinkova</surname><given-names>D</given-names></name><name><surname>Celer</surname><given-names>VJ</given-names></name><name><surname>Jahn</surname><given-names>P</given-names></name></person-group><year>2004</year><article-title>Isolation and partial characterization of equine herpesvirus type
1 in Czechia</article-title><source>Folia Microbiol</source><volume>49</volume><fpage>605</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">15702554</pub-id></element-citation></ref><ref id="B15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>E</given-names></name><name><surname>Mori</surname><given-names>CMC</given-names></name><name><surname>Massironi</surname><given-names>SMG</given-names></name><etal/></person-group><year>2009</year><article-title>Detection of equid herpesvirus 1 DNA by Polymerase Chain Reaction
after experimental inoculation of horses with a Brazilian A4/72
strain</article-title><source>Braz J Vet Res Anim Sci</source><volume>46</volume><fpage>253</fpage><lpage>261</lpage></element-citation></ref><ref id="B16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>CM</given-names></name><name><surname>Mori</surname><given-names>E</given-names></name><name><surname>Favaro</surname><given-names>LL</given-names></name><etal/></person-group><year>2012</year><article-title>Equid Herpesvirus Type-1 Exhibits Neurotropism and Neurovirulence
in a Mouse Model</article-title><source>J Comp Pathol</source><volume>146</volume><fpage>202</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">21689826</pub-id></element-citation></ref><ref id="B17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>M</given-names></name><name><surname>Correa</surname><given-names>W</given-names></name></person-group><year>1966</year><article-title>Isolamento do virus do aborto equino no Estado de Sao
Paulo</article-title><source>Arq Inst Biol</source><volume>33</volume><fpage>23</fpage><lpage>25</lpage></element-citation></ref><ref id="B18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nugent</surname><given-names>J</given-names></name><name><surname>Birch-Machin</surname><given-names>I</given-names></name><name><surname>Smith</surname><given-names>K</given-names></name><etal/></person-group><year>2006</year><article-title>Analysis of equid herpesvirus 1 strain variation reveals a point
mutation of the DNA polymerase strongly associated with neuropathogenic
<italic>vs</italic>. nonneuropathogenic disease
outbreaks</article-title><source>J Virol</source><volume>80</volume><fpage>4047</fpage><lpage>4060</lpage><pub-id pub-id-type="pmid">16571821</pub-id></element-citation></ref><ref id="B19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagamjav</surname><given-names>O</given-names></name><name><surname>Sakata</surname><given-names>T</given-names></name><name><surname>Matsumura</surname><given-names>T</given-names></name><etal/></person-group><year>2005</year><article-title>Natural recombinant between equine herpesviruses 1 and 4 in the
ICP4 gene</article-title><source>Microbiol Immunol</source><volume>49</volume><fpage>167</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">15722602</pub-id></element-citation></ref><ref id="B20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinnoji</surname><given-names>RC</given-names></name><name><surname>Bedadala</surname><given-names>GR</given-names></name><name><surname>George</surname><given-names>B</given-names></name><etal/></person-group><year>2007</year><article-title>Repressor element-1 silencing transcription factor/neuronal
restrictive silencer factor (REST/NRSF) can regulate HSV-1 immediate-early
transcription via histone modification</article-title><source>Virol J</source><volume>4</volume><fpage>56</fpage><pub-id pub-id-type="pmid">17555596</pub-id></element-citation></ref><ref id="B21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamura</surname><given-names>K</given-names></name><name><surname>Stecher</surname><given-names>G</given-names></name><name><surname>Peterson</surname><given-names>D</given-names></name><etal/></person-group><year>2013</year><article-title>MEGA6: Molecular Evolutionary Genetics Analysis version
6.0</article-title><source>Mol Biol Evol</source><volume>30</volume><fpage>2725</fpage><lpage>2729</lpage><pub-id pub-id-type="pmid">24132122</pub-id></element-citation></ref><ref id="B22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandekerckhove</surname><given-names>AP</given-names></name><name><surname>Glorieux</surname><given-names>S</given-names></name><name><surname>Gryspeerdt</surname><given-names>AC</given-names></name><etal/></person-group><year>2010</year><article-title>Replication kinetics of neurovirulent <italic>vs</italic>.
non-neurovirulent equine herpesvirus type 1 strains in equine nasal mucosal
explants</article-title><source>J Gen Virol</source><volume>91</volume><fpage>2019</fpage><lpage>2028</lpage><pub-id pub-id-type="pmid">20427565</pub-id></element-citation></ref><ref id="B23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varrasso</surname><given-names>A</given-names></name><name><surname>Dynon</surname><given-names>K</given-names></name><name><surname>Ficorilli</surname><given-names>N</given-names></name><etal/></person-group><year>2001</year><article-title>Identification of equine herpesviruses 1 and 4 by polymerase
chain reaction</article-title><source>Aust Vet J</source><volume>79</volume><fpage>563</fpage><lpage>569</lpage><pub-id pub-id-type="pmid">11599819</pub-id></element-citation></ref><ref id="B24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whalley</surname><given-names>J</given-names></name><name><surname>Ruitenberg</surname><given-names>K</given-names></name><name><surname>Sullivan</surname><given-names>K</given-names></name><etal/></person-group><year>2007</year><article-title>Host cell tropism of equine herpesviruses: glycoprotein D of
EHV-1 enables EHV-4 to infect a non-permissive cell line</article-title><source>Arch Virol</source><volume>152</volume><fpage>717</fpage><lpage>725</lpage><pub-id pub-id-type="pmid">17171298</pub-id></element-citation></ref></ref-list><app-group><app><label>Supplementaty Material</label><p>Figure S1: Amino acid sequence alignment among EHV-1 Brazilian isolates (A4/72,
A3/97, ISO07/05, ISO11/06 and ISO33/06) and Genbank reference EHV-1 strains
(Ab4, KyD, V592, RacL11, HVS25A, KyA and Ab1) gD sequences.</p><supplementary-material content-type="local-data" id="suppl01"><media xlink:href="1517-8382-bjm-46-2-565-suppl01.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group></back></article>